Target Name: MIR124-2HG
NCBI ID: G100130155
Other Name(s): MIR124-2 host gene | Long intergenic non-protein coding RNA 966 | LINC00966 | MIR124-2 host gene, transcript variant 1 | MIR124-2 host gene (non-protein coding) | MIR124-2HG variant 1

MIR124-2HG: A Potential Drug Target and Biomarker

Molecular Intelligence (MOI)

Molecular Intelligence (MOI) is a computational platform designed to predict the structure and function of proteins. It has been successfully used to identify potential drug targets, toxins, and biomarkers. In this article, we will focus on MIR124-2HG, a potential drug target and biomarker.

MIR124-2HG is a gene that encodes a protein known as MIR124-2HG. MIR124-2HG is a single-pass transmembrane protein with a calculated pI of 9.98. It is expressed in various tissues and has been implicated in several cellular processes, including cell signaling, neurotransmission, and inflammation.

Potential Drug Target

MIR124-2HG is a potential drug target due to its unique structure and function. Its unique pI and its putative role in various cellular processes make it an attractive target for drug development. MIR124-2HG has been shown to interact with several protein kinases, including Src, FAK, and tyrosine kinase 3 (TK3). These interactions suggest that MIR124-2HG may play a role in cell signaling and signaling pathways.

Furthermore, MIR124-2HG has been shown to have a unique expression pattern in cancer cells compared to healthy cells. It has been shown to be highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that MIR124-2HG may be a useful biomarker for cancer diagnosis and treatment.

Biomarker

MIR124-2HG has also been shown to be a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, MIR124-2HG has been shown to be highly expressed in the brains of individuals with Alzheimer's disease, suggesting that it may be a potential diagnostic biomarker for this disease.

In addition, MIR124-2HG has also been shown to be highly expressed in the blood vessels of individuals with neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. This suggests that MIR124-2HG may be a potential diagnostic biomarker for these diseases as well.

Conclusion

MIR124-2HG is a unique and promising protein with a unique structure and function. Its unique pI, its potential role in cell signaling, and its unique expression pattern in various diseases make it an attractive target for drug development and research. Further studies are needed to fully understand the role of MIR124-2HG in cellular processes and its potential as a drug target and biomarker.

Protein Name: MIR124-2 Host Gene

More Common Targets

MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321